G

Genmab
GMAB

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
DKK83.50B
EV
DKK63.43B
Shares Outstanding
62.31M
Beta
0.96

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
DKK2081.92
P/E 2025E
12.92x
P/Revenue 2025E
3.39x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Genmab A/S

gainify

G

Genmab A/S

GMAB

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid...

Sector

Healthcare

Industry

Biotechnology

CEO

de Winkel, Jan G.J.

Employees

2,682

IPO Date

2000-10-20

Headquarters

Carl Jacobsens Vej 30, Valby, Copenhagen, Capital Region of Denmark, 2500, Denmark

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved